← Back to Clinical Trials
Recruiting NCT07530900

NCT07530900 Prediction of Visual Feedback Effects on Speech Motor Adaptation in Healthy Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07530900
Status Recruiting
Phase
Sponsor New York University
Condition Healthy Volunteers
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-04-27
Primary Completion 2026-08-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Altered Auditory Feedback (AAF)Visual-Acoustic Biofeedback

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-04-27 with a primary completion date of 2026-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study examines whether individual differences in how speakers respond to hearing versus physical sensation during speech can predict who benefits most from visual feedback during a speech task. Healthy adults will complete a series of tasks in which auditory feedback is altered in real time through headphones, with and without an added visual display of the speech signal. A computational model will be used to estimate how strongly each participant relies on hearing versus physical sensation when monitoring speech. The study will then test whether this individual profile predicts how much the visual display improves each participant's ability to respond to the altered feedback.

Eligibility Criteria

Inclusion Criteria: * Age 18 to 45 years * Self-reported English as dominant or equally dominant language (learned English by age 3) * No self-reported history of significant speech, language, or hearing difficulty * Pass pure-tone hearing screening at 25 dB HL * Pass qualitative screening of speech, voice, and resonance based on connected speech sample Exclusion Criteria: * Learned English after age 3 * English is not a dominant language * History of speech or language disorder, hearing loss, or neurodevelopmental disorder (e.g., autism spectrum disorder, Down syndrome) * Failure to pass pure-tone hearing screening * Failure to pass qualitative screening of speech, voice, and resonance

Contact & Investigator

Central Contact

Tara McAllister, PhD

✉ tkm214@nyu.edu

📞 212-992-9445

Principal Investigator

Tara McAllister, PhD

PRINCIPAL INVESTIGATOR

New York University

Frequently Asked Questions

Who can join the NCT07530900 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07530900 currently recruiting?

Yes, NCT07530900 is actively recruiting participants. Contact the research team at tkm214@nyu.edu for enrollment information.

Where is the NCT07530900 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07530900 clinical trial?

NCT07530900 is sponsored by New York University. The principal investigator is Tara McAllister, PhD at New York University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology